Consider validity, clinical relevance, and applicability of albumin for critically ill patients

Comment

M Offringa. BMJ. 1998.

. 1998 Aug 1;317(7154):343.

doi: 10.1136/bmj.317.7154.343.

No abstract available

Comment in

Beyond conflict of interest. What is truth as it relates to albumin?
Dearlove O. Dearlove O. BMJ. 1999 Feb 13;318(7181):464. doi: 10.1136/bmj.318.7181.464a. BMJ. 1999. PMID: 9974475 Free PMC article. No abstract available.

Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful.
Offringa M. Offringa M. BMJ. 1998 Jul 25;317(7153):223-4. doi: 10.1136/bmj.317.7153.223. BMJ. 1998. PMID: 9677204 Free PMC article. No abstract available.
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.
Cochrane Injuries Group Albumin Reviewers. Cochrane Injuries Group Albumin Reviewers. BMJ. 1998 Jul 25;317(7153):235-40. doi: 10.1136/bmj.317.7153.235. BMJ. 1998. PMID: 9677209 Free PMC article.

1. Offringa M. Excess mortality after human albumin administration in critically ill patients. BMJ. 1998;317:223–224. . (25 July.) - PMC - PubMed
1. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235–240. . (25 July.) - PMC - PubMed